Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
2.150
-0.070 (-3.15%)
At close: Aug 14, 2026, 4:00 PM EDT
2.165
+0.015 (0.68%)
After-hours: Aug 14, 2026, 7:59 PM EDT
Autolus Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 171.41 | 104.13 | 227.38 | 239.57 | 382.44 | 310.34 |
Short-Term Investments | 30.22 | 196.58 | 360.64 | - | - | - |
Cash & Short-Term Investments | 201.63 | 300.71 | 588.02 | 239.57 | 382.44 | 310.34 |
Cash Growth | -55.62% | -48.86% | 145.45% | -37.36% | 23.23% | 102.44% |
Accounts Receivable | - | 24.55 | 0.95 | 1.05 | 0.15 | 0.07 |
Other Receivables | - | 51.24 | 47.3 | 23.5 | 28.82 | 26.18 |
Receivables | - | 75.79 | 48.24 | 24.54 | 28.98 | 26.25 |
Inventory | - | 33.21 | 4.14 | - | - | - |
Prepaid Expenses | - | 21.28 | 15.21 | 8.64 | 12.34 | 8.71 |
Restricted Cash | - | 1.5 | 1.43 | 0.77 | 0.33 | 0.34 |
Other Current Assets | 134.46 | 3.43 | 3.89 | 1.79 | 1.7 | 1.31 |
Total Current Assets | 336.09 | 435.92 | 660.93 | 275.3 | 425.77 | 346.95 |
Property, Plant & Equipment | - | 128.5 | 105.05 | 95.65 | 58.42 | 52.32 |
Other Intangible Assets | - | 19.81 | 12.37 | - | - | 0.07 |
Long-Term Deferred Tax Assets | - | 3.56 | 3.24 | 3.06 | 2.08 | 1.83 |
Other Long-Term Assets | 157.14 | 1.28 | 1.13 | 1.36 | 4.01 | 4.4 |
Total Assets | 493.23 | 589.07 | 782.73 | 375.38 | 490.27 | 405.56 |
Accounts Payable | - | 3.08 | 1.97 | 0.1 | 0.53 | 0.43 |
Accrued Expenses | - | 53.76 | 51.8 | 39.05 | 40.4 | 23.51 |
Current Portion of Leases | - | 4.57 | 3 | 5.05 | 5.04 | 4.45 |
Other Current Liabilities | 68.79 | 12.03 | 3.98 | 0.53 | 0.39 | 0.16 |
Total Current Liabilities | 68.79 | 73.44 | 60.74 | 44.74 | 46.37 | 28.55 |
Long-Term Debt | - | 270.2 | 244.6 | 170.9 | 125.9 | 47.02 |
Long-Term Leases | - | 66.82 | 49.63 | 47.91 | 19.22 | 16.55 |
Other Long-Term Liabilities | 424.44 | 0.48 | 0.43 | 0.36 | 0.12 | 0.13 |
Total Liabilities | 493.23 | 410.94 | 355.4 | 263.91 | 191.6 | 92.24 |
Common Stock | - | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
Additional Paid-In Capital | - | 1,570 | 1,556 | 1,019 | 1,008 | 843.11 |
Retained Earnings | - | -1,387 | -1,099 | -878.56 | -670.18 | -521.34 |
Comprehensive Income & Other | - | -5.24 | -29.06 | -28.87 | -38.78 | -8.45 |
Shareholders' Equity | - | 178.13 | 427.33 | 111.47 | 298.67 | 313.32 |
Total Liabilities & Equity | 493.23 | 589.07 | 782.73 | 375.38 | 490.27 | 405.56 |
Total Debt | - | 341.59 | 297.23 | 223.87 | 150.16 | 68.01 |
Net Cash (Debt) | 201.63 | -40.88 | 290.79 | 15.7 | 232.28 | 242.32 |
Net Cash Growth | 38.95% | - | 1752.19% | -93.24% | -4.15% | 144.43% |
Net Cash Per Share | 0.76 | -0.15 | 1.14 | 0.09 | 2.45 | 3.36 |
Filing Date Shares Outstanding | 266.16 | 266.14 | 266.13 | 265.93 | 173.07 | 90.91 |
Total Common Shares Outstanding | 266.16 | 266.14 | 266.12 | 174.1 | 173.07 | 90.91 |
Working Capital | 267.3 | 362.48 | 600.19 | 230.57 | 379.41 | 318.4 |
Book Value Per Share | - | 0.67 | 1.61 | 0.64 | 1.73 | 3.45 |
Tangible Book Value | - | 158.32 | 414.95 | 111.47 | 298.67 | 313.26 |
Tangible Book Value Per Share | - | 0.59 | 1.56 | 0.64 | 1.73 | 3.45 |
Machinery | - | 65.12 | 50.42 | 38.37 | 35.98 | 38.92 |
Construction In Progress | - | 27.08 | 19.64 | 12.54 | 13.19 | 2.44 |
Leasehold Improvements | - | 15.76 | 14.12 | 12.73 | 11.69 | 14.9 |